Who is the CEO of Medistep Healthcare Ltd?
- Answer Field
-
The CEO of Medistep Healthcare Ltd is Mr. Girdharilal Prajapat.
BAJAJ BROKING
Medistep Healthcare Limited, incorporated in June 2023, is involved in the manufacturing and trading of healthcare and wellness products. Its portfolio includes sanitary pads, energy powders, pharmaceuticals, nutraceuticals, intimate care items, and surgical products. The company operates as a public, non-government entity with an aim to expand its product line and strengthen its position in the healthcare sector. With a focus on both essential and lifestyle-driven health products, Medistep caters to a range of consumer and medical needs.
As of December 30, 2024, the company reported annualised revenues of ₹45.00 crore and a Profit After Tax (PAT) of ₹4.08 crore. Medistep’s operational workforce includes nine full-time employees, with additional manpower sourced through daily-paid labourers. None of the labour force is on a contractual basis. The IPO is intended to support business expansion, manufacturing scale-up, and broader market penetration, offering insights into the company’s direction and future plans.
For more details, visit the Medistep Healthcare IPO page.
Details | Information |
IPO Date | August 8, 2025 to August 12, 2025 |
Issue Size | 37,44,000 shares (aggregating up to ₹16.10 Cr) |
Price Band | ₹43 per share |
Lot Size | 3000 shares |
Listing At | NSE SME |
Market Maker | Nirman Share Brokers Private Limited |
Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility
Working Capital Requirements
General Corporate Purpose
Event | Date |
---|---|
IPO Open Date | Fri, Aug 8, 2025 |
IPO Close Date | Tue, Aug 12, 2025 |
Tentative Allotment | Wed, Aug 13, 2025 |
Initiation of Refunds | Thu, Aug 14, 2025 |
Credit of Shares to Demat | Thu, Aug 14, 2025 |
Tentative Listing Date | Mon, Aug 18, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on August 12, 2025 |
₹43 per share
Application | Lots | Shares | Amount |
Individual investors (Retail) (Min) | 2 | 6,000 | ₹2,58,000 |
Individual investors (Retail) (Max) | 2 | 6,000 | ₹2,58,000 |
HNI (Min) | 3 | 9,000 | ₹3,87,000 |
Log in to Your Trading Account: Access your trading account through your broker’s platform.
Navigate to the IPO Section: Go to the IPO section to view active IPO listings.
Select Medistep Healthcare IPO: Find "Medistep Healthcare IPO" and click on the ‘Apply’ button.
Enter Application Details: Specify the number of lots (minimum lot size: 3000 shares) and the bid price within the range of ₹43 per share.
Provide Your UPI ID: Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.
Review and Submit: Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on August 12, 2025, to complete your application process.
Additional Read- How to Apply for the Medistep Healthcare IPO?
Total Assets: Grew from ₹14.66 crore in FY24 to ₹22.99 crore as of March 2025.
Total income: Reached ₹49.66 crore in FY25.
Profit After Tax (PAT): Stood at ₹4.14 crore for March 2025.
Net Worth: Recorded at ₹16.83 crore in FY25.
Reserves and Surplus: Recorded at ₹6.37 crore (March 2025), growing steadily over the years.
EBITDA: Stood at ₹5.60 crore in March 2025.
The company has shown a steady increase in its asset base, indicating business expansion and operational scaling.
Its overall income reflects consistent growth, supported by increasing demand and product reach.
Profitability has improved, showing better cost management and enhanced revenue generation.
The rise in net worth suggests improved financial stability and internal value creation.
Growth in reserves and surplus highlights the company’s ability to retain earnings and strengthen its financial position.
Operating performance has shown positive momentum, backed by better margins and efficient resource utilisation.
The company has a short operating history, having been incorporated in 2023, which may limit the visibility of long-term performance and business sustainability.
Its small workforce and reliance on daily-wage labourers may impact operational efficiency and scalability during periods of high demand or workforce disruption.
The IPO proceeds are planned for capacity expansion and working capital support, which could enable the company to broaden its manufacturing capabilities and market presence.
With a diverse product range in the healthcare and wellness space, the company is positioned to cater to increasing consumer demand across essential and lifestyle healthcare segments.
KPI | Values |
ROE | 29.06% |
ROCE | 38.91% |
RoNW | 29.06% |
PAT Margin | 8.35% |
EBITDA Margin | 11.27% |
Price to Book Value | 2.67 |
Registrar | Lead Manager(s) |
---|---|
Cameo Corporate Services Limited | Fast Track Finsec Pvt Ltd |
Medistep Healthcare Ltd. 05, S. No-245/B, Plot-19, T.P.S. 56, Free Way Trade Center, Nr.A-One Hotel N.H.-8 Narol Gam, Narol Daskroi, Ahmedabad, Gujarat, 382405
Phone: +91 87808 46963
Email: Info@medistephc.com
Website: https://www.medistephc.com/
Medistep Healthcare Limited operates in the healthcare and wellness segment with a focus on sanitary pads, energy supplements, pharmaceuticals, and surgical products. The company has outlined its intention to expand production and strengthen market outreach using funds raised through its IPO. It operates as a public, non-government entity and has built its product portfolio to serve both consumer and medical markets.
The IPO provides insight into the company’s business model, growth strategy, and recent financial developments. With a short operational history and a lean workforce structure, the business continues to evolve. Investors may review the company’s objectives, risks, and financials to understand its current position and future direction.
Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Medistep Healthcare IPO.
Share this article:
No result found
The CEO of Medistep Healthcare Ltd is Mr. Girdharilal Prajapat.
The Medistep Healthcare IPO is scheduled to open for subscription on August 8, 2025, and will close on August 12, 2025.
Medistep Healthcare Ltd is involved in the manufacturing and trading of healthcare and wellness products, including sanitary pads, energy powders, pharmaceuticals, nutraceuticals, intimate care items, and surgical products. The business model is based on demand for essential and wellness-based healthcare items, with future sustainability dependent on market conditions, operational scalability, and effective execution of expansion plans.
The issue size of the IPO is 37,44,000 equity shares, aggregating up to ₹16.10 crore.
‘Pre-apply’ allows investors to place their IPO orders before the official subscription window opens. Orders placed during this phase are submitted once the IPO opens, offering convenience and a chance to avoid last-minute rush.
You will receive a confirmation after successfully approving the UPI mandate. The order is officially placed once the mandate is accepted and funds are blocked from your linked bank account.
The lot size for the IPO is 3,000 shares. The minimum order quantity for retail investors is 2 lots, i.e., 6,000 shares, amounting to ₹2,58,000.
The tentative date for allotment is August 13, 2025.
The registrar for the IPO is Cameo Corporate Services Limited.
Based on publicly available information and IPO disclosures, no governance-related red flags or structural issues have been highlighted. However, detailed due diligence by investors is advisable before making any investment decision.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading